BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12605347)

  • 1. Limited value of serum steroid measurements in identification of mild form of 21-hydroxylase deficiency.
    Török D; Halász Z; Garami M; Homoki J; Fekete G; Sólyom J
    Exp Clin Endocrinol Diabetes; 2003 Feb; 111(1):27-32. PubMed ID: 12605347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas.
    Patócs A; Tóth M; Barta C; Sasvári-Székely M; Varga I; Szücs N; Jakab C; Gláz E; Rácz K
    Eur J Endocrinol; 2002 Sep; 147(3):349-55. PubMed ID: 12213672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and urinary steroids in girls with precocious pubarche and/or hirsutism due to mild 3-beta-hydroxysteroid dehydrogenase deficiency.
    Sólyom J; Halász Z; Hosszú E; Gláz E; Vihko R; Orava M; Homoki J; Wudy SA; Teller WM
    Horm Res; 1995; 44(3):133-41. PubMed ID: 7590644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two different radioimmunoassays to measure 17-hydroxyprogesterone during treatment monitoring of children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kamrath C; Böhles H; Maser-Gluth C
    Clin Chim Acta; 2011 Jan; 412(1-2):186-9. PubMed ID: 20933513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocorticotrophin stimulation and HLA polymorphisms suggest a high frequency of heterozygosity for steroid 21-hydroxylase deficiency in patients with Turner's syndrome and their families.
    Larizza D; Cuccia M; Martinetti M; Maghnie M; Dondi E; Salvaneschi L; Severi F
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):39-45. PubMed ID: 8306479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency.
    Weintrob N; Brautbar C; Pertzelan A; Josefsberg Z; Dickerman Z; Kauschansky A; Lilos P; Peled D; Phillip M; Israel S
    Eur J Endocrinol; 2000 Sep; 143(3):397-403. PubMed ID: 11022183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17-Hydroxyprogesterone in children, adolescents and adults.
    Honour JW
    Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne.
    Ostlere LS; Rumsby G; Holownia P; Jacobs HS; Rustin MH; Honour JW
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):209-15. PubMed ID: 9579234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
    Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
    J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation and evidence for CYP21B gene point mutations in true precocious puberty.
    Cisternino M; Dondi E; Martinetti M; Lorini R; Salvaneschi L; Cuccia M; Severi F
    Clin Endocrinol (Oxf); 1998 May; 48(5):555-60. PubMed ID: 9666866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization.
    Sólyom J; Gács G; Keszei K; Láng K; Orley J; Petheö I; Ságodi L
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):413-8. PubMed ID: 3039770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Shibata Y
    Nihon Naibunpi Gakkai Zasshi; 1991 Aug; 67(8):819-39. PubMed ID: 1813324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche.
    Ghizzoni L; Cappa M; Vottero A; Ubertini G; Carta D; Di Iorgi N; Gasco V; Marchesi M; Raggi V; Ibba A; Napoli F; Massimi A; Maghnie M; Loche S; Porzio O
    Eur J Endocrinol; 2011 Aug; 165(2):307-14. PubMed ID: 21646284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of nonclassical congenital adrenal hyperplasia in patients with precocious adrenarche.
    Morris AH; Reiter EO; Geffner ME; Lippe BM; Itami RM; Mayes DM
    J Clin Endocrinol Metab; 1989 Oct; 69(4):709-15. PubMed ID: 2550505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
    Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway.
    Fiet J; Gueux B; Raux-DeMay MC; Kuttenn F; Vexiau P; Brerault JL; Couillin P; Galons H; Villette JM; Julien R
    J Clin Endocrinol Metab; 1989 Mar; 68(3):542-7. PubMed ID: 2537337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital adrenal hyperplasia in adolescents: diagnosis and management.
    Lin-Su K; Nimkarn S; New MI
    Ann N Y Acad Sci; 2008; 1135():95-8. PubMed ID: 18574213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of late-onset congenital adrenal hyperplasia in clinical practice: current evaluation.
    Sahmay S; Tuten A; Gurleyen H; Oncul M; Benian A; Tamer Erel C
    Minerva Endocrinol; 2014 Sep; 39(3):215-22. PubMed ID: 25068307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 21-Hydroxylase deficiency: an exemplary model of the contribution of molecular biology in the understanding and management of the disease.
    Forest MG; Tardy V; Nicolino M; David M; Morel Y
    Ann Endocrinol (Paris); 2005 Jun; 66(3):225-32. PubMed ID: 15988383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
    Pham-Huu-Trung MT; Gourmelen M; Raux-Eurin MC; Girard F
    J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.